These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15304397)

  • 1. PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.
    Cook WD; McCaw BJ; Herring C; John DL; Foote SJ; Nutt SL; Adams JM
    Blood; 2004 Dec; 104(12):3437-44. PubMed ID: 15304397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous PU.1 mutations are associated with acute myeloid leukemia.
    Mueller BU; Pabst T; Osato M; Asou N; Johansen LM; Minden MD; Behre G; Hiddemann W; Ito Y; Tenen DG
    Blood; 2002 Aug; 100(3):998-1007. PubMed ID: 12130514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia.
    Brown N; Finnon R; Manning G; Bouffler S; Badie C
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():48-54. PubMed ID: 26520372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
    Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-Rate-Dependent PU.1 Inactivation to Develop Acute Myeloid Leukemia in Mice Through Persistent Stem Cell Proliferation After Acute or Chronic Gamma Irradiation.
    Ojima M; Hirouchi T; Etani R; Ariyoshi K; Fujishima Y; Kai M
    Radiat Res; 2019 Dec; 192(6):612-620. PubMed ID: 31560640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.
    Metcalf D; Dakic A; Mifsud S; Di Rago L; Wu L; Nutt S
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1486-91. PubMed ID: 16432184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells.
    Schmidt M; Bies J; Tamura T; Ozato K; Wolff L
    Blood; 2004 Jun; 103(11):4142-9. PubMed ID: 14976051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
    Yamada T; Kondoh N; Matsumoto M; Yoshida M; Maekawa A; Oikawa T
    Blood; 1997 Feb; 89(4):1383-93. PubMed ID: 9028962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
    Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
    J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts.
    Durual S; Rideau A; Ruault-Jungblut S; Cossali D; Beris P; Piguet V; Matthes T
    Leukemia; 2007 May; 21(5):1050-9. PubMed ID: 17361223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemogenesis in heterozygous PU.1 knockout mice.
    Genik PC; Vyazunova I; Steffen LS; Bacher JW; Bielefeldt-Ohmann H; McKercher S; Ullrich RL; Fallgren CM; Weil MM; Ray FA
    Radiat Res; 2014 Sep; 182(3):310-5. PubMed ID: 25076114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1 regulates the expression of the human neutrophil elastase gene.
    Srikanth S; Rado TA
    Biochim Biophys Acta; 1998 Jun; 1398(2):215-23. PubMed ID: 9689920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of PML is essential for activation of C/EBP epsilon and PU.1 to accelerate granulocytic differentiation.
    Tagata Y; Yoshida H; Nguyen LA; Kato H; Ichikawa H; Tashiro F; Kitabayashi I
    Leukemia; 2008 Feb; 22(2):273-80. PubMed ID: 17989716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain.
    Fisher RC; Olson MC; Pongubala JM; Perkel JM; Atchison ML; Scott EW; Simon MC
    Mol Cell Biol; 1998 Jul; 18(7):4347-57. PubMed ID: 9632818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.
    Tschan MP; Reddy VA; Ress A; Arvidsson G; Fey MF; Torbett BE
    Oncogene; 2008 May; 27(24):3489-93. PubMed ID: 18193090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia.
    Aue G; Du Y; Cleveland SM; Smith SB; Davé UP; Liu D; Weniger MA; Metais JY; Jenkins NA; Copeland NG; Dunbar CE
    Blood; 2011 Oct; 118(17):4674-81. PubMed ID: 21878674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.